After decades of work, an atypical schizophrenia drug is approved The therapy met its primary endpoints in two Phase 3 studies and offers a new approach for the tens of millions of people living with the psychiatric condition.

https://www.drugdiscoverynews.com/after-decades-of-work-an-atypical-schizophrenia-drug-is-approved-16126?utm_campaign=DDN_Newsletter_Dose&utm_medium=email&_hsenc=p2ANqtz--YZcARrqDKXdM7bxdmehzI0C4beqzVoGakhtw3ppW8CBKGic-vin484dX-9CVe-lieimgxXNHftl2JBN0zoQW3jGzZ9w&_hsmi=333601152&utm_content=333601152&utm_source=hs_email